Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients with Acute Coronary Syndromes

Circulation

Volumn 108, Issue 23, 2003, Pages 2864-2869

  Golino, Paolo ^a,b   Ravera, Amelia ^a   Ragni, Massimo ^a   Cirillo, Plinio ^a   Piro, Orlando ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Acute coronary syndromes; Inhibitors, tissue factor pathway; Tissue factor

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 10A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOPEPTIDE A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; NITRATE; PROTHROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; AORTA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; IN VIVO STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STABLE ANGINA PECTORIS; THROMBOGENESIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; AORTA; CORONARY CIRCULATION; CORONARY THROMBOSIS; CORONARY VESSELS; FACTOR XA; FEMALE; FIBRINOLYSIS; FIBRINOPEPTIDE A; HEPARIN; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PROTHROMBIN; STENTS; THROMBIN; THROMBOPHILIA;

EID: 0345599092     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000105900.21445.3D     Document Type: Article

References (35)

1. Davies MJ, Woolf N. Atherosclerosis: what is it and why does it occur? Br Heart J. 1993;69(suppl):S3-S11.
2. Wilcox JN, Smith KN, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 1989;86:2839-2843.
3. Annex BH, Denning SM, Channon KM, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995;91:619-622.
4. Toschi V, Gallo R, Lettino M, et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
5. Badimon JJ, Lettino M, Toschi V, et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation. 1999;99:1780-1787.
6. Jang IK, Gold HK, Leinbach RC, et al. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb. 1992;12:948-954.
7. Pawashe AB, Golino P, Ambrosio G, et al. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 1994;74:56-63.
8. Ragni M, Cirillo P, Pascucci I, et al. A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation. 1996;93:1913-1920.
9. Golino P, Ragni M, Cirillo P, et al. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ Res. 1998;82:39-46.
10. Broze Jr GJ. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol. 1992;29:159-169.
11. Broze GJ Jr, Warren LA, Novotny WF, et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988;71:335-343.
12. Ganz W, Tamura K, Marcus HS, et al. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971;144:181-195.
13. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation inhibitor (EPI). Thromb Res. 1988;50:803-813.
14. Novotny WF, Brown SG, Miletich JP, et al. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood. 1991;78:387-393.
15. Novotny WF, Girard TJ, Miletich JP, et al. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem. 1989;264:18831-18837.
16. Lesnik P, Vonica A, Guerin M, et al. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb Vasc Biol. 1993;13:1066-1075.
17. Kawaguchi A, Miyao Y, Noguchi T, et al. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and post-heparin lipoprotein lipase but proportional to apolipoprotein A-II. Arterioscler Thromb Vasc Biol. 2000;20:251-258.
18. Gouin-Thibault I, Dewar L, Craven S, et al. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo. Br J Haematol. 1996;95:738-746.
19. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanisms in unstable angina and myocardial infarction. Circulation. 1994;90:61-68.
20. Merlini PA, Ardissino D, Bauer K, et al. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol. 1997;17:1325-1330.
21. Broze GJ Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coag Fibrinol. 1995;6:S7-S13.
22. Sandset PM, Abildgaard U. Extrinsic pathway inhibitor-the key to feedback control of blood coagulation initiated by tissue thromboplastin. Haemostasis. 1991;21:219-239.
23. Novotny WF, Girard TJ, Miletich JP, et al. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein-associated coagulation inhibitor. Blood 1988;72:2020-2025.
24. Sandset PM, Warn-Cramer BJ, Rao LVM, et al. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci U S A. 1991;88:708-715.
25. Ragni M, Golino P, Cirillo P, et al. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury. Circulation. 2000;102:113-117.
26. Haskel EJ, Torr SR, Day KC, et al. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation. 1991;84:821-827.
27. Golino P, Cirillo P, Calabrò P, et al. Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in inured rabbit carotid arteries. J Am Coll Cardiol. 2001;38:569-576.
28. Westrick RJ, Bodary PF, Xu ZJ, et al. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation. 2001;103:3044-3046.
29. Crawley J, Lupu F, Westmuckett AD, et al. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol. 2000;20:1362-1373.
30. Drew AF, Davenport P, Apostolopoulos J, et al. Tissue factor pathway inhibitor expression in atherosclerosis. Lab Invest. 1997;77:291-298.
31. Kaikita K, Takeya M, Ogawa H, et al. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol. 1999;188:180-188.
32. Soejima H, Ogawa H, Yasue H, et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation. 1999;99:2908-2913.
33. Lupu C, Lupu F, Dennehy U, et al. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol. 1995;15:2055-2062.
34. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311-2315.
35. Huang ZF, Higuchi D, Lasky N, et al. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 1997;90:944-951.